The oral and lower airway microbiota and coronary heart disease in COPD patients and controls
PLOS One · 16.07.2026 · 21 (7) · e0353738
DOI: 10.1371/journal.pone.0353738 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.07.2026. Verfasst von Christina Due Svendsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Microbiota, Coronary Disease, Mouth. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest.
Themen: COPD
Abstract (Originalsprache)
Background
Chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD) are major causes of morbidity and mortality, with shared risk factors and often co-occurring. This study investigated the association between both the oral and lower airway microbiome and CHD in healthy controls and COPD patients.
Methods
228 participants from the MicroCOPD study (101 controls and 127 COPD patients) underwent coronary CT angiography to assess calcium score (CaSc) and coronary stenosis. Oral wash (OW) and bronchoalveolar lavage (BAL) samples were collected. Microbial DNA was analyzed using 16S rRNA gene sequencing with the Illumina MiSeq platform. Microbiome composition and diversity were analysed using established pipelines in Quantitative Insights into Microbial Ecology 2 (QIIME 2) and R.
Results
Alpha diversity (Shannon index) differed significantly between COPD patients and controls in OW (p < 0.01), but not BAL. No statistically significant alpha (Shannon or Faith’s PD) diversity differences were found between CHD and non-CHD groups. Beta diversity analysis (Bray-Curtis dissimilarity) revealed no significant differences in microbial composition between CHD and non-CHD groups, both for COPD patients and controls (p > 0.05). Firmicutes dominated across all subgroups, followed by Bacteroidetes and Actinobacteria . Several taxa were found to be differentially abundant between CHD and non-CHD groups but comprised less than 1% of all taxa.
Conclusion
The microbiome differed between COPD patients and controls, but we could not find evidence that either the oral or lower airway microbiome differed between those with and without coronary heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
- Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
- Department of Biomedicine, University of Bergen, Bergen, Norway.
ORCID-Profile: Christina Due Svendsen, Rune Nielsen
Förderung
- Helse Vest
Zitieren
APA
Svendsen, C. D., Nielsen, R., Larsen, T. H., Kuiper, K. K. J., & Eagan, T. M. (2026). The oral and lower airway microbiota and coronary heart disease in COPD patients and controls. PLOS One, 21(7), e0353738. https://doi.org/10.1371/journal.pone.0353738
Vancouver
Svendsen CD, Nielsen R, Larsen TH, Kuiper KKJ, Eagan TM. The oral and lower airway microbiota and coronary heart disease in COPD patients and controls. PLOS One. 2026;21(7):e0353738. doi:10.1371/journal.pone.0353738
BibTeX
@article{Svendsen2026,
author = {Svendsen, Christina Due and Nielsen, Rune and Larsen, Terje H and Kuiper, Karel K J and Eagan, Tomas M},
title = {The oral and lower airway microbiota and coronary heart disease in COPD patients and controls},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0353738},
doi = {10.1371/journal.pone.0353738}
}
EUVIMED